HALEON PLC-ADR (HLN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:HLN - US4055521003 - ADR
10.11 USD
+0.03 (+0.3%)
10.11 USD
0 (0%)
HLN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 191 industry peers in the Pharmaceuticals industry. While HLN has a great profitability rating, there are some minor concerns on its financial health. HLN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year HLN was profitable.
In the past year HLN had a positive cash flow from operations.
In the past 5 years HLN has always been profitable.
Each year in the past 5 years HLN had a positive operating cash flow.
1.2 Ratios
HLN's Return On Assets of 4.20% is amongst the best of the industry. HLN outperforms 85.34% of its industry peers.
Looking at the Return On Equity, with a value of 8.92%, HLN belongs to the top of the industry, outperforming 84.29% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 6.11%, HLN belongs to the top of the industry, outperforming 83.77% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for HLN is significantly below the industry average of 12.85%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| ROIC | 6.11% |
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
1.3 Margins
HLN has a better Profit Margin (12.84%) than 85.34% of its industry peers.
HLN's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 21.31%, HLN belongs to the top of the industry, outperforming 89.01% of the companies in the same industry.
HLN's Operating Margin has improved in the last couple of years.
HLN's Gross Margin of 60.75% is fine compared to the rest of the industry. HLN outperforms 70.68% of its industry peers.
In the last couple of years the Gross Margin of HLN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.31% | ||
| PM (TTM) | 12.84% | ||
| GM | 60.75% |
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HLN is destroying value.
HLN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for HLN has been reduced compared to 5 years ago.
The debt/assets ratio for HLN is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.32 indicates that HLN is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.32, HLN is in the better half of the industry, outperforming 61.78% of the companies in the same industry.
The Debt to FCF ratio of HLN is 5.11, which is a neutral value as it means it would take HLN, 5.11 years of fcf income to pay off all of its debts.
HLN has a better Debt to FCF ratio (5.11) than 82.20% of its industry peers.
A Debt/Equity ratio of 0.53 indicates that HLN is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.53, HLN is not doing good in the industry: 64.92% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 5.11 | ||
| Altman-Z | 2.32 |
ROIC/WACC0.75
WACC8.2%
2.3 Liquidity
A Current Ratio of 0.98 indicates that HLN may have some problems paying its short term obligations.
The Current ratio of HLN (0.98) is worse than 85.34% of its industry peers.
HLN has a Quick Ratio of 0.98. This is a bad value and indicates that HLN is not financially healthy enough and could expect problems in meeting its short term obligations.
HLN's Quick ratio of 0.78 is on the low side compared to the rest of the industry. HLN is outperformed by 84.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.78 |
3. Growth
3.1 Past
HLN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.59%.
The Earnings Per Share has been growing by 17.56% on average over the past years. This is quite good.
Looking at the last year, HLN shows a decrease in Revenue. The Revenue has decreased by -0.61% in the last year.
Measured over the past years, HLN shows a small growth in Revenue. The Revenue has been growing by 5.78% on average per year.
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-5.33%
3.2 Future
HLN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.10% yearly.
HLN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.76% yearly.
EPS Next Y5.74%
EPS Next 2Y8.04%
EPS Next 3Y8.69%
EPS Next 5Y10.1%
Revenue Next Year-1.32%
Revenue Next 2Y1.63%
Revenue Next 3Y2.58%
Revenue Next 5Y3.76%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
HLN is valuated rather expensively with a Price/Earnings ratio of 20.22.
HLN's Price/Earnings ratio is rather cheap when compared to the industry. HLN is cheaper than 80.10% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.51, HLN is valued a bit cheaper.
With a Price/Forward Earnings ratio of 17.44, HLN is valued on the expensive side.
HLN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HLN is cheaper than 79.58% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.13, HLN is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.22 | ||
| Fwd PE | 17.44 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, HLN is valued cheaper than 81.68% of the companies in the same industry.
84.82% of the companies in the same industry are more expensive than HLN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.86 | ||
| EV/EBITDA | 15.2 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HLN does not grow enough to justify the current Price/Earnings ratio.
HLN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.52
PEG (5Y)1.15
EPS Next 2Y8.04%
EPS Next 3Y8.69%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.83%, HLN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 0.61, HLN pays a better dividend. On top of this HLN pays more dividend than 92.67% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.00, HLN has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.83% |
5.2 History
HLN has been paying a dividend for at least 10 years, so it has a reliable track record.
HLN has decreased its dividend recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
39.53% of the earnings are spent on dividend by HLN. This is a low number and sustainable payout ratio.
DP39.53%
EPS Next 2Y8.04%
EPS Next 3Y8.69%
10.11
+0.03 (+0.3%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners56.78%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap45.02B
Revenue(TTM)11.23B
Net Income(TTM)1.44B
Analysts79.17
Price Target11.45 (13.25%)
Short Float %0.32%
Short Ratio1.51
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.83% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP39.53%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.58%
Min EPS beat(2)-1.92%
Max EPS beat(2)7.08%
EPS beat(4)3
Avg EPS beat(4)3.76%
Min EPS beat(4)-1.92%
Max EPS beat(4)7.54%
EPS beat(8)4
Avg EPS beat(8)-10.37%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.51%
Min Revenue beat(2)-5.38%
Max Revenue beat(2)-1.64%
Revenue beat(4)0
Avg Revenue beat(4)-3.11%
Min Revenue beat(4)-5.38%
Max Revenue beat(4)-1.64%
Revenue beat(8)1
Avg Revenue beat(8)-2.55%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.24%
PT rev (3m)-3.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.66%
EPS NY rev (1m)0.31%
EPS NY rev (3m)1.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)0.38%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.22 | ||
| Fwd PE | 17.44 | ||
| P/S | 2.98 | ||
| P/FCF | 16.86 | ||
| P/OCF | 14.53 | ||
| P/B | 2.07 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.2 |
EPS(TTM)0.5
EY4.95%
EPS(NY)0.58
Fwd EY5.74%
FCF(TTM)0.6
FCFY5.93%
OCF(TTM)0.7
OCFY6.88%
SpS3.4
BVpS4.89
TBVpS-3.04
PEG (NY)3.52
PEG (5Y)1.15
Graham Number7.42
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.2% | ||
| ROE | 8.92% | ||
| ROCE | 8.4% | ||
| ROIC | 6.11% | ||
| ROICexc | 6.63% | ||
| ROICexgc | 4145.85% | ||
| OM | 21.31% | ||
| PM (TTM) | 12.84% | ||
| GM | 60.75% | ||
| FCFM | 17.65% |
ROA(3y)3.44%
ROA(5y)3.54%
ROE(3y)7.24%
ROE(5y)6.28%
ROIC(3y)6.15%
ROIC(5y)5.77%
ROICexc(3y)6.57%
ROICexc(5y)6.04%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.5%
ROCE(5y)8.01%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y12.56%
ROICexc growth 5Y14.99%
OM growth 3Y-0.45%
OM growth 5Y3.75%
PM growth 3Y-4.12%
PM growth 5Y10.69%
GM growth 3Y0.43%
GM growth 5Y0.58%
F-Score6
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 5.11 | ||
| Debt/EBITDA | 3.18 | ||
| Cap/Depr | 98.15% | ||
| Cap/Sales | 2.83% | ||
| Interest Coverage | 6.65 | ||
| Cash Conversion | 84.66% | ||
| Profit Quality | 137.52% | ||
| Current Ratio | 0.98 | ||
| Quick Ratio | 0.78 | ||
| Altman-Z | 2.32 |
F-Score6
WACC8.2%
ROIC/WACC0.75
Cap/Depr(3y)107.06%
Cap/Depr(5y)107.33%
Cap/Sales(3y)2.94%
Cap/Sales(5y)3.03%
Profit Quality(3y)156.45%
Profit Quality(5y)128.12%
High Growth Momentum
Growth
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%N/A
EPS Next Y5.74%
EPS Next 2Y8.04%
EPS Next 3Y8.69%
EPS Next 5Y10.1%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-5.33%
Revenue Next Year-1.32%
Revenue Next 2Y1.63%
Revenue Next 3Y2.58%
Revenue Next 5Y3.76%
EBIT growth 1Y4.68%
EBIT growth 3Y5.1%
EBIT growth 5Y9.75%
EBIT Next Year11.73%
EBIT Next 3Y8.42%
EBIT Next 5Y7.85%
FCF growth 1Y12.42%
FCF growth 3Y23.3%
FCF growth 5Y29.57%
OCF growth 1Y9.57%
OCF growth 3Y19.28%
OCF growth 5Y23.96%
HALEON PLC-ADR / HLN FAQ
Can you provide the ChartMill fundamental rating for HALEON PLC-ADR?
ChartMill assigns a fundamental rating of 6 / 10 to HLN.
Can you provide the valuation status for HALEON PLC-ADR?
ChartMill assigns a valuation rating of 6 / 10 to HALEON PLC-ADR (HLN). This can be considered as Fairly Valued.
How profitable is HALEON PLC-ADR (HLN) stock?
HALEON PLC-ADR (HLN) has a profitability rating of 8 / 10.
Can you provide the PE and PB ratios for HLN stock?
The Price/Earnings (PE) ratio for HALEON PLC-ADR (HLN) is 20.22 and the Price/Book (PB) ratio is 2.07.
Can you provide the dividend sustainability for HLN stock?
The dividend rating of HALEON PLC-ADR (HLN) is 5 / 10 and the dividend payout ratio is 39.53%.